Live search
TopFind is fetching the latest matches for your search.
We reviewed 43 live results for interleukin inhibitor and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Interleukin Inhibitor and Immunosuppressant.
Sumber: Skyrizi
Deskripsi
An interleukin inhibitor (IL-23) used for the treatment of active ulcerative colitis and moderate to severe plaque psoriasis. This biologic therapy targets specific immune pathways to reduce inflammation and promote healing.
Paling cocok untuk
plaque psoriasis treatment, active ulcerative colitis relief and IL-23 inhibitor preference
Penilaian
Sumber: Novartis Malaysia
Deskripsi
Cosentyx (Secukinumab) is an interleukin inhibitor prescribed for plaque psoriasis and psoriatic arthritis. It is supplied as a 150 mg/mL solution for injection in a pre-filled pen or syringe.
Paling cocok untuk
plaque psoriasis, psoriatic arthritis and interleukin inhibition
Penilaian
Sumber: Novartis Corporation (Malaysia) Sdn. Bhd.
Deskripsi
Secukinumab solution for injection available in a pre-filled pen or pre-filled syringe. This interleukin-17A (IL-17A) inhibitor is indicated for the treatment of moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis in adults who are candidates for systemic therapy or phototherapy.
Paling cocok untuk
plaque psoriasis patients, psoriatic arthritis management, ankylosing spondylitis treatment and self-injection at home
Penilaian
| Bandingkan | Skyrizi (Risankizumab) | Cosentyx | Cosentyx 150mg/ml |
|---|---|---|---|
| Sumber | Skyrizi | Novartis Malaysia | Novartis Corporation (Malaysia) Sdn. Bhd. |
| Deskripsi | An interleukin inhibitor (IL-23) used for the treatment of active ulcerative colitis and moderate to severe plaque psoriasis. This biologic therapy targets specific immune pathways to reduce inflammation and promote healing. | Cosentyx (Secukinumab) is an interleukin inhibitor prescribed for plaque psoriasis and psoriatic arthritis. It is supplied as a 150 mg/mL solution for injection in a pre-filled pen or syringe. | Secukinumab solution for injection available in a pre-filled pen or pre-filled syringe. This interleukin-17A (IL-17A) inhibitor is indicated for the treatment of moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis in adults who are candidates for systemic therapy or phototherapy. |
| Paling cocok untuk | plaque psoriasis treatment, active ulcerative colitis relief and IL-23 inhibitor preference | plaque psoriasis, psoriatic arthritis and interleukin inhibition | plaque psoriasis patients, psoriatic arthritis management, ankylosing spondylitis treatment and self-injection at home |
| Tag | |||
| Aksi | Lihat detail | Lihat detail | Lihat detail |
| Penilaian |
Jika Anda ingin memulai dari opsi yang paling seimbang, saya merekomendasikan:
"Skyrizi (Risankizumab) from Skyrizi."
Saya memilih ini karena A newly approved biologic in Singapore (2025) providing advanced relief for chronic psoriasis and ulcerative colitis.